Our stock is traded on the Nasdaq under the symbol CTXR.
2010
September 2014
On March 30, 2016, Citius acquired Leonard-Meron Biosciences, Inc. (“LMB”) as a wholly-owned subsidiary. The Company acquired all of the outstanding stock of LMB by issuing shares of its common stock.
On September 11, 2020, Citius formed NoveCite, Inc., a Delaware corporation, of which Citius owns 75% of the issued and outstanding capital stock.
11 Commerce Drive, First Floor Cranford, NJ 07016
September 30th
VStock Transfer LLC 18 Lafayette Place Woodmere, NY 11598 T: 212-828-8436 www.vstocktransfer.com
Wolf & Company, P.C. 99 High Street Boston, MA 02110
Wyrick Robbins Yates & Ponton LLP 4101 Lake Boone Trail Suite 300 Raleigh, NC 27607 www.wyrick.com
Citius Pharmaceuticals, Inc. Tel: (908) 967-6677 Email: info@citiuspharma.com